Development and QA of IGRT procedures for node-positive prostate cancer patients in the PEARLS trial

被引：0
|
作者：
Naismith, O. [1 ]
Alexander, S. [2 ,3 ]
Webster, A. [4 ]
Miles, E. [5 ]
Hassan, S. [6 ]
Murray, J. [7 ,8 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Radiotherapy Trials QA Grp RTTQA, London, England
[2] Royal Marsden NHS Fdn Trust, Radiotherapy Trials QA Grp RTTQA, Sutton, Surrey, England
[3] Inst Canc Res, Radiotherapy, Sutton, Surrey, England
[4] Univ Coll London Hosp UCLH, Radiotherapy Trials QA Grp RTTQA, London, England
[5] Mt Vernon Hosp, Radiotherapy Trials QA Grp RTTQA, Northwood, Middx, England
[6] Inst Canc Res, Clin Trials & Stat Unit, Sutton, Surrey, England
[7] Royal Marsden NHS Fdn Trust, Radiotherapy, Sutton, Surrey, England
[8] Inst Canc Res, Clin Oncol, Sutton, Surrey, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0421
引用
收藏
页码：S323 / S324
页数：2
相关论文
共 50 条
  • [21] Is Radiotherapy Useful in Node-Positive Prostate Cancer Patients after Radical Prostatectomy?
    Van Poppel, Hein
    EUROPEAN UROLOGY, 2009, 55 (05) : 1012 - 1013
  • [22] Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
    Huan Chen
    Min Qu
    Haoqing Shi
    Zhenyang Dong
    Yan Wang
    Xu Gao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4925 - 4932
  • [23] Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment
    Abdollah, Firas
    Karnes, R. Jeffrey
    Suardi, Nazareno
    Cozzarini, Cesare
    Gandaglia, Giorgio
    Fossati, Nicola
    Bianchi, Marco
    Boorjian, Stephen A.
    Sun, Maxine
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY, 2014, 65 (03) : 554 - 562
  • [24] Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer
    Xiao-xiao Guo
    Run-qi Guo
    Hui-min Hou
    Xuan Wang
    Jian-ye Wang
    Ming Liu
    International Journal of Clinical Oncology, 2020, 25 : 2115 - 2121
  • [25] Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer
    Muralidhar, Vinayak
    Mahal, Brandon A.
    Rose, Brent S.
    Chen, Yu-Wei
    Nezolosky, Michelle D.
    Efstathiou, Jason A.
    Beard, Clair J.
    Martin, Neil E.
    Orio, Peter F., III
    Quoc-Dien Trinh
    Choueiri, Toni K.
    Sweeney, Christopher J.
    Nguyen, Paul L.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : 563 - +
  • [26] Whole pelvis radiotherapy for pathological node-positive prostate cancer
    Poelaert, Filip
    Fonteyne, Valerie
    Ost, Piet
    De Troyer, Bart
    Decaestecker, Karel
    De Meerleer, Gert
    De Visschere, Pieter
    Claeys, Tom
    Dhondt, Bert
    Lumen, Nicolaas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (06) : 444 - 451
  • [27] Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer
    Guo, Xiao-xiao
    Guo, Run-qi
    Hou, Hui-min
    Wang, Xuan
    Wang, Jian-ye
    Liu, Ming
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2115 - 2121
  • [28] Node-Positive Prostate Cancer: A Call for Level 1 Evidence
    Gandaglia, Giorgio
    Karnes, R. Jeffrey
    Cozzarini, Cesare
    Montorsi, Francesco
    Briganti, Alberto
    ONCOLOGY-NEW YORK, 2015, 29 (02): : 118 - +
  • [29] Toxicity and outcome of pelvic IMRT for node-positive prostate cancer
    Mueller, A. -C.
    Luetjens, J.
    Alber, M.
    Eckert, F.
    Bamberg, M.
    Schilling, D.
    Belka, C.
    Ganswindt, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (11) : 982 - 989
  • [30] Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer
    Wong, Yu-Ning
    Freedland, Stephen
    Egleston, Brian
    Hudes, Gary
    Schwartz, J. Sanford
    Armstrong, Katrina
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) : 100 - 105
12345